Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

Ibrutinib remains a key treatment for relapsed chronic lymphocytic leukemia (CLL), but findings suggest that combining it ...

Chris Lopez was the youngest colon cancer patient his oncologist had ever treated. At 29, Chris was 16 years younger than the ...

A US-based surgeon is urging youngsters to get their colonoscopy and complete health screening done as cases of colorectal or ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

Edward Ratner has lived with chronic lymphocytic leukemia for a decade. Here, the Minneapolis doctor shares his rules for success.

Feb. 26, 2025 — Scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... New Innovative Local ...

December 14th 2023Access Considerations for Gene Therapies Among Patients With Rare Diseases ...

Researchers have discovered a strong association between the use of immune checkpoint inhibitors for cancer treatment and a risk of new onset psoriasis.